Core Insights - Veeva Systems holds a strong market position with recurring revenue from subscription services and is well-positioned to benefit from the AI trend in healthcare [1][2] Industry Overview - The pharmaceutical industry is increasingly interested in applying AI to enhance the drug discovery process, although AI cannot predict human responses to drugs [4] - AI can improve the efficiency of the initial drug candidate selection process, which typically involves screening thousands of molecules [5] Company Analysis - Veeva Systems has been developing an industry cloud for life sciences that integrates regulatory, clinical, and commercial data, enhancing the efficiency of drug discovery [7][8] - The company offers a suite of software services tailored for the biopharmaceutical sector, including a customer relationship management service that is gaining traction [7] - With extensive data on drug sales and development, Veeva's AI services could further increase the stickiness of its software subscriptions [7]